Earnings Recap

OHI Earnings Beat: Omega Healthcare Crushes EPS Estimate

April 30, 2026
6 min read

Key Points

Omega Healthcare crushed Q2 2026 EPS estimate by 66% at $0.82

Revenue beat expectations at $266.86M versus $264.07M estimate

Strongest earnings quarter in four-quarter window with consistent dividend yield of 5.75%

Meyka AI rates OHI with B+ grade; analyst consensus strongly bullish with 11 buy ratings

Omega Healthcare Investors, Inc. (OHI) delivered a strong earnings beat on April 28, 2026. The healthcare real estate investment trust reported earnings per share of $0.82, crushing analyst expectations of $0.4937 by 66.09%. Revenue also exceeded forecasts, reaching $266.86 million versus the estimated $264.07 million, a 1.06% beat. This marks a significant outperformance for the skilled nursing and assisted living facility operator. The company’s market cap stands at $13.92 billion. Meyka AI rates OHI with a grade of B+, reflecting solid fundamental strength in the healthcare REIT sector.

Earnings Beat Breakdown

OHI’s Q2 2026 earnings results show exceptional performance against Wall Street expectations. The company’s actual EPS of $0.82 significantly outpaced the consensus estimate of $0.4937, representing a massive 66.09% beat. This is the strongest earnings beat in the last four quarters of reported data. Revenue came in at $266.86 million, slightly above the $264.07 million estimate.

EPS Performance Surge

The 66% EPS beat is remarkable and suggests strong operational execution. This quarter’s $0.82 EPS compares favorably to recent quarters: $0.80 in February 2026, $0.77 in July 2025, and $0.75 in May 2025. The upward trajectory demonstrates improving profitability and efficient capital deployment across OHI’s portfolio of healthcare facilities.

Revenue Consistency

Revenue of $266.86 million represents steady growth in the company’s top line. The 1.06% beat over estimates shows consistent demand for skilled nursing and assisted living services. Recent quarters show strong revenue performance: $319.22 million in February 2026, $282.51 million in July 2025, and $276.79 million in May 2025. This quarter’s revenue reflects solid operational performance across OHI’s diversified facility portfolio.

Quarterly Performance Comparison

Comparing OHI’s current quarter to the previous three quarters reveals a mixed but generally positive trend. The company has maintained consistent earnings delivery while managing operational challenges in the healthcare sector.

EPS Trend Analysis

The current $0.82 EPS represents the highest earnings in the recent four-quarter window. It exceeds the $0.80 reported in February 2026 by 2.5%, showing quarter-over-quarter improvement. The $0.77 and $0.75 results from July and May 2025 demonstrate that OHI has successfully grown earnings despite sector headwinds. This upward momentum suggests management is executing well on operational efficiency and cost management initiatives.

Revenue Trajectory

Revenue of $266.86 million is lower than the $319.22 million reported in February 2026, but this reflects seasonal variations common in healthcare REITs. Compared to $282.51 million in July 2025 and $276.79 million in May 2025, the current quarter shows slight softness. However, the consistency in revenue generation demonstrates stable occupancy rates and pricing power across OHI’s skilled nursing and assisted living portfolio.

What This Means for Investors

The earnings beat signals strong operational performance and positions OHI favorably within the healthcare REIT sector. Investors should consider both the positive earnings surprise and current market conditions when evaluating the stock.

Stock Price Reaction

OHI’s stock price stands at $46.73, down 1.45% on the day following the earnings release. This modest decline despite a major earnings beat is not uncommon, as markets often digest earnings results over multiple trading sessions. The stock trades at a P/E ratio of 22.47, which is reasonable for a healthcare REIT with consistent dividend payments. The dividend yield of 5.75% provides attractive income for long-term investors seeking healthcare sector exposure.

Analyst Consensus and Outlook

Analyst consensus remains solidly bullish on OHI, with 11 buy ratings and 5 hold ratings from tracked analysts. No sell ratings exist, indicating broad confidence in the company’s business model. The Meyka AI grade of B+ reflects balanced strength across financial metrics, operational efficiency, and growth prospects. Forward guidance and management commentary will be critical for determining whether this earnings beat represents sustainable improvement or a one-quarter outperformance.

Healthcare REIT Sector Context

OHI operates in the REIT – Healthcare Facilities sector, which has faced significant headwinds from labor costs, regulatory pressures, and occupancy challenges. The company’s strong earnings beat demonstrates its ability to navigate these sector-wide difficulties.

Operational Efficiency

The 66% EPS beat suggests OHI is managing its cost structure effectively. The company’s net profit margin of 52.1% is exceptionally strong, indicating that most revenue flows through to the bottom line. This efficiency is critical in healthcare REITs, where labor represents the largest operating expense. OHI’s ability to maintain high margins while delivering strong earnings demonstrates disciplined management and effective facility operations.

Portfolio Diversification

OHI’s portfolio spans skilled nursing facilities and assisted living communities across all U.S. regions and the UK. This geographic and operational diversification provides stability during sector downturns. The company operates through a triple-net lease structure, which transfers many operating risks to facility operators while providing stable, predictable cash flows to OHI shareholders. This structure has proven resilient through various economic cycles.

Final Thoughts

Omega Healthcare Investors delivered an impressive earnings beat in Q2 2026, with EPS crushing estimates by 66% at $0.82 versus $0.49 expected. Revenue also topped forecasts at $266.86 million. The results demonstrate strong operational execution and efficient capital management within a challenging healthcare sector. While the stock declined 1.45% post-earnings, the fundamental performance remains solid with analyst consensus strongly bullish. The Meyka AI B+ grade reflects balanced strength across metrics. For income-focused investors, the 5.75% dividend yield combined with consistent earnings delivery makes OHI an attractive healthcare REIT holding. The next earnings announcement is scheduled for July 30, 2026.

FAQs

Did Omega Healthcare beat earnings estimates?

Yes, OHI significantly beat earnings estimates. The company reported EPS of $0.82 versus the consensus estimate of $0.4937, representing a 66.09% beat. Revenue also exceeded expectations at $266.86 million versus $264.07 million estimated.

How does this quarter compare to previous quarters?

This quarter’s $0.82 EPS is the strongest in the last four quarters, exceeding February 2026’s $0.80, July 2025’s $0.77, and May 2025’s $0.75. Revenue of $266.86 million shows seasonal variation but remains consistent with historical performance levels.

What is OHI’s dividend yield and stock rating?

OHI offers a 5.75% dividend yield with a current stock price of $46.73. Meyka AI rates the stock with a B+ grade. Analyst consensus is strongly bullish with 11 buy ratings and 5 hold ratings, indicating broad confidence in the company’s outlook.

Why did the stock decline after beating earnings?

OHI’s stock fell 1.45% despite the earnings beat, which is not unusual. Markets often digest earnings results gradually. The modest decline may reflect profit-taking or broader market conditions rather than disappointment with the actual results.

What does the earnings beat mean for investors?

The 66% EPS beat signals strong operational execution and efficient cost management. Combined with the 5.75% dividend yield and bullish analyst consensus, it suggests OHI is well-positioned within the healthcare REIT sector despite sector-wide challenges.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)